carboplatin - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
CARBOPLATIN ACCORD carboplatin 450 mg/45 mL solution for injection vial
AUST R: 215854
Active ingredients:
carboplatin

Dosage form:
Injection, solution

Sponsor:
Accord Healthcare Pty Ltd

Phone:
1800 222 673

From
18 Nov 2024
to
28 Mar 2025

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

Management action:
The sponsor is working to expedite the next shipment. An unregistered product has been approved for supply under Section 19A. The approval holder, ORSPEC Pharma Pty Ltd, can be contacted for details on supply on 02 4339 4239.
DBL CARBOPLATIN 150mg/15mL injection vial
AUST R: 46845
Active ingredients:
carboplatin

Dosage form:
Injection, solution

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800-675-229

From
11 Feb 2025
to
11 Apr 2025

Shortage status:
Current

Availability:
Limited Availability

Reason:
Unexpected increase in demand due to other sponsors unable to supply

Management action:
The sponsor is working to expedite the next shipment. Patients are advised to consult their healthcare professional to discuss alternative treatment options.
DBL CARBOPLATIN 450mg/45mL injection vial
AUST R: 46846
Active ingredients:
carboplatin

Dosage form:
Injection, solution

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800-675-229

From
21 Jan 2025
to
14 Mar 2025

Shortage status:
Current

Availability:
Unavailable

Reason:
Unexpected increase in demand due to other sponsors unable to supply

Management action:
The sponsor is working to expedite the next shipment. An unregistered product has been approved for supply under Section 19A. The approval holder, ORSPEC Pharma Pty Ltd, can be contacted for details on supply on 02 4339 4239.